Institutional investors purchased a net $2.5 million shares of ILMN during the quarter ended June 2015 and now own 98.75% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
LONE PINE CAPITAL LLC Bought 2.8 Million shares of Illumina Inc
SANDS CAPITAL MANAGEMENT LLC Bought 2.7 Million shares of Illumina Inc
WELLINGTON MANAGEMENT CO. LLP Bought 2.3 Million shares of Illumina Inc